120 related articles for article (PubMed ID: 37792847)
1. Auranofin sensitizes breast cancer cells to paclitaxel chemotherapy by disturbing the cellular redox system.
Natarajan D; Prasad NR; Sudharsan M; Bharathiraja P; Lakra DS
Cell Biochem Funct; 2023 Dec; 41(8):1305-1318. PubMed ID: 37792847
[TBL] [Abstract][Full Text] [Related]
2. Auranofin sensitizes breast cancer cells to paclitaxel mediated cell death via regulating FOXO3/Nrf2/Keap1 signaling pathway.
Deepika N; Rajendra Prasad N; Radhiga T
Cell Biochem Funct; 2024 Jan; 42(1):e3903. PubMed ID: 38269508
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with auranofin and nutlin-3a induces synergistic cytotoxicity in breast cancer cells.
Ye DJ; Kwon YJ; Baek HS; Cho E; Kwon TU; Chun YJ
J Toxicol Environ Health A; 2019; 82(10):626-637. PubMed ID: 31258040
[TBL] [Abstract][Full Text] [Related]
4. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
5. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
6. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
7. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Allison SE; Chen Y; Petrovic N; Zhang J; Bourget K; Mackenzie PI; Murray M
Biochem Pharmacol; 2017 Nov; 143():79-89. PubMed ID: 28756208
[TBL] [Abstract][Full Text] [Related]
8. Galbanic acid: Induced antiproliferation in estrogen receptor-negative breast cancer cells and enhanced cellular redox state in the human dermal fibroblasts.
Sajjadi M; Karimi E; Oskoueian E; Iranshahi M; Neamati A
J Biochem Mol Toxicol; 2019 Nov; 33(11):e22402. PubMed ID: 31576639
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with auranofin and trametinib induces synergistic apoptosis in breast cancer cells.
Joo MK; Shin S; Ye DJ; An HG; Kwon TU; Baek HS; Kwon YJ; Chun YJ
J Toxicol Environ Health A; 2021 Jan; 84(2):84-94. PubMed ID: 33103613
[TBL] [Abstract][Full Text] [Related]
10. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
Wang Z; Butt K; Wang L; Liu H
Nutr Cancer; 2007; 58(2):230-8. PubMed ID: 17640170
[TBL] [Abstract][Full Text] [Related]
11. Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells.
Kwiatkowska E; Wojtala M; Gajewska A; Soszyński M; Bartosz G; Sadowska-Bartosz I
J Bioenerg Biomembr; 2016 Feb; 48(1):23-32. PubMed ID: 26715289
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
13. Redox homeostasis of breast cancer lineages contributes to differential cell death response to exogenous hydrogen peroxide.
Hecht F; Cazarin JM; Lima CE; Faria CC; Leitão AA; Ferreira AC; Carvalho DP; Fortunato RS
Life Sci; 2016 Aug; 158():7-13. PubMed ID: 27328417
[TBL] [Abstract][Full Text] [Related]
14. Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling.
Sun T; Liu Y; Li M; Yu H; Piao H
Mol Cell Probes; 2020 Oct; 53():101602. PubMed ID: 32447047
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation.
Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV
Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells.
Gote V; Sharma AD; Pal D
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513992
[TBL] [Abstract][Full Text] [Related]
17. Baker's Yeast Sensitizes Metastatic Breast Cancer Cells to Paclitaxel In Vitro.
Badr El-Din NK; Mahmoud AZ; Hassan TA; Ghoneum M
Integr Cancer Ther; 2018 Jun; 17(2):542-550. PubMed ID: 29161917
[TBL] [Abstract][Full Text] [Related]
18. Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells.
Lee JE; Kwon YJ; Baek HS; Ye DJ; Cho E; Choi HK; Oh KS; Chun YJ
Arch Pharm Res; 2017 Jun; 40(6):746-759. PubMed ID: 28560500
[TBL] [Abstract][Full Text] [Related]
19. Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.
Hatem E; Azzi S; El Banna N; He T; Heneman-Masurel A; Vernis L; Baïlle D; Masson V; Dingli F; Loew D; Azzarone B; Eid P; Baldacci G; Huang ME
J Natl Cancer Inst; 2019 Jun; 111(6):597-608. PubMed ID: 30779852
[TBL] [Abstract][Full Text] [Related]
20. Zerumbone-induced reactive oxygen species-mediated oxidative stress re-sensitizes breast cancer cells to paclitaxel.
Li J; Wang L; Sun Y; Wang Z; Qian Y; Duraisamy V; Antary TMA
Biotechnol Appl Biochem; 2023 Feb; 70(1):28-37. PubMed ID: 35240000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
